Abstract: An experimental device and method for supercritical CO2/H2O mixed fluid huff and puff for shale oil development includes a CO2 storage tank, a water vapor generator, a mixing vessel, and a core holder; the CO2 storage tank and the water vapor generator are in communication with the mixing vessel; a first pressure gauge and a hygronom are connected to an upper end of the mixing vessel, and a displacement pump is connected to a lower end of the mixing vessel; the mixing vessel is connected to an inlet end of the core holder; the core holder is connected to an inlet end of a drying pipe, and the measuring cylinder is disposed upside down in a liquid containing dish, where the liquid containing dish and the measuring cylinder are filled with a saturated sodium carbonate solution.

Abstract: A steerable arm for use in endoscopic surgical procedures. The steerable arm cut from a tube of nitinol to provide flexibility and resilience by the structure into which the tube is cut. Typically, the cut tube comprises a spiralling coil, the loops of which are in contact on one lateral side of the tube and the tube is bent to open apart the loops on the other lateral side. The material which the tube is made of is capable of retaining memory of the bend. This provides a bias for restoring the tube to the bend whenever a force causing the tube to flex is removed.

Abstract: The disclosure provides nucleic acids, and variants and fragments thereof, obtained from strains of Bacillus thuringiensis encoding polypeptides having pesticidal activity against insect pests, including Lepidopteran and Coleopteran. Particular embodiments of the disclosure provide isolated nucleic acids encoding pesticidal proteins, pesticidal compositions, DNA constructs, and transformed microorganisms and plants comprising a nucleic acid of the embodiments. These compositions find use in methods for controlling pests, especially plant pests.

Abstract: The present disclosure discloses a deformation and control simulation test system for a tunnel engineering supporting structure, including a follow-up hoisting platform, actuators, a control system. It is horizontal structure. The follow-up hoisting platform reduces the friction caused by the weight of testing sample and facilitates experimental operations. Each actuator fixed on an annular box body reaction frame can move independently through a control system in form of force control or displacement control mode, and can achieve circumferential contraction loading through its gomphodont configuration. The hinged and curved design of the cushion blocks of actuators can adapt to the circumferential contraction deformation of a test sample and maintain a close fit with them during the loading process.

Abstract: A testing device for simulating coalbump includes a testing chamber. A first oil cylinder, a second oil cylinder and a third oil cylinder are provided within the testing chamber; each piston rod of each oil cylinder can stretch or retract. A first reaction seat, a second reaction seat and a third reaction seat are arranged opposite to a side of the first piston rod of the first oil cylinder, a side of the second piston rod of the second oil cylinder and a side of the third piston rod of the third oil cylinder respectively. The testing device includes a shear loading unit including a fourth oil cylinder and a fifth oil cylinder located on a same axis, and a side of a fourth piston rod of the fourth oil cylinder and a side of a fifth piston rod of the fifth oil cylinder are arranged opposite to each other.

Abstract: The present disclosure discloses a deformation and control simulation test system for a tunnel engineering supporting structure, including a follow-up hoisting platform, actuators, a control system. It is horizontal structure. The follow-up hoisting platform reduces the friction caused by the weight of testing sample and facilitates experimental operations. Each actuator fixed on an annular box body reaction frame can move independently through a control system in form of force control or displacement control mode, and can achieve circumferential contraction loading through its gomphodont configuration. The hinged and curved design of the cushion blocks of actuators can adapt to the circumferential contraction deformation of a test sample and maintain a close fit with them during the loading process.

Abstract: The invention provides a kind of phycocyanin taro ball and preparation method thereof, consisting of the following components in parts by mass: 0.5-2 parts of phycocyanin powder, 45-55 parts of acetic acid-chitosan solution, 50-150 parts of sodium alginate solution, 200-300 parts of taro, 20-30 parts of granulated sugar, 100-200 parts of tapioca starch. The invention adds sodium alginate and chitosan in the preparation process to enhance the flexibility of taro balls, and with the health effects of non-toxic, antioxidant, anti-inflammatory, anti-cancer, hepatoprotective and immunity-enhancing of phycocyanin. Therefore, the phycocyanin taro balls provided by the invention is a kind of food with health care function. The invention not only improves the nutritional value of taro balls, but also increases the market popularity of phycocyanin.

Abstract: Provided herein are compounds, salts, crystalline forms, and pharmaceutical compositions that are related to Selective Estrogen Receptor Degraders, as well as methods of preparing the same. Also provided herein are methods of using the compounds, salts, crystalline forms, and pharmaceutical compositions for the treatment of diseases or disorders, such as breast cancer.

Abstract: A privacy protection method for the electronic device includes: starting face change detection, where the face change detection is continuously detecting, in a current unlocking period, whether a face in front of a display of the electronic device changes; after starting the face change detection, detecting an operation of starting a first private application; and in response to the operation and determining that a result of the face change detection is that the current face does not change, displaying first private content corresponding to the first private application; or in response to the operation and determining that a result of the face change detection is that the current face changes, displaying first non-private content, where the first non-private content does not include first private content.

Abstract: The present disclosure relates to the technical field of lithium-ion battery, and particularly, to an electrolytic solution and a lithium-ion battery including the electrolytic solution. The electrolytic solution includes additives, and the additives include an additive A and an additive B. The additive A forms a film on the surface of the positive electrode and effectively prevents interface side reactions at the positive electrode. Comparing with the additive A, the additive B is preferentially reduced to form a film at the negative electrode, avoiding an increase in impedance and deterioration of cycling dynamic performance, etc., caused by film formation of the additive A on the negative electrode. The combination of the additive A and additive B imparts the battery with a reduced gas production, a higher capacity retention rate and a lower impedance at high temperature.

Abstract: The technology relates generally to the field of immunology and relates in part to compositions and methods for growing and storing modified natural killer cells, including for example, conditional chemical regulation of natural killer cell function. The technology further relates to pharmaceutical compositions and treatment of subjects using modified natural killer cells.

Abstract: The present invention discloses a Lithium ion battery and an electrolyte thereof, the electrolyte comprising an organic solvent, a lithium salt and an additive. The additive comprises a cyclic fluoro carbonate (A), a cyclic phosphazene (B), a cyclic sulfate and a lithium fluoro oxalate borate (D). The lithium fluoro oxalate borate (D) has following formula: Compared with the prior art, the electrolyte of the present invention may form a stable CEI and SEI film on the surface of positive and negative electrodes, protect the interface between positive and negative electrodes, improve the acidic atmosphere of Lithium ion battery electrolyte, and reduce the damage effect of HF on the interface between positive and negative electrodes, while reducing low temperature resistance of lithium-ion battery, improving cycle life, high temperature storage performance, safety performance and rate capability of lithium-ion battery.

Abstract: The present disclosure provides an electrolyte and an electrochemical energy storage device, the electrolyte comprises an electrolyte salt and an additive. The additive comprises a sulfonic ester cyclic quaternary ammonium salt and a multinitrile compound. The sulfonic ester cyclic quaternary ammonium salt and the multinitrile compound can form a dense and uniform passive film with high ionic conductivity on a surface of each of the positive electrode film and the negative electrode film, so as to prevent continuous oxidation and reduction reaction from occurring between the electrolyte and the positive electrode film and the negative electrode film and make the electrochemical energy storage device has excellent high temperature cycle performance and high temperature storage performance.

Abstract: The present invention provides a use of a rifamycin-quinolizidone coupling molecule, or a stereoisomer, hydrate, deuterium-substituted form, ester, solvate, crystal form, metabolite, pharmaceutically acceptable salt or prodrug thereof in resisting nontuberculous mycobacteria. The rifamycin-quinolizidone coupling molecule has a structure shown in formula (I) The rifamycin-quinolizidone coupling molecule, or the stereoisomer, hydrate, deuterium, ester, solvate, crystal form, metabolite, pharmaceutically acceptable salt or prodrug thereof may effectively against nontuberculous mycobacteria, and then may be used for treating infection caused by human nontuberculous mycobacteria.

Abstract: The present invention provides a use of a rifamycin-nitroimidazole coupling molecule, or a stereoisomer, hydrate, deuterium-substituted form, ester, solvate, crystal form, metabolite, pharmaceutically acceptable salt or prodrug thereof in resisting nontuberculous mycobacteria. The rifamycin-nitroimidazole coupling molecule has a structure shown in formula (I) below. The rifamycin-nitroimidazole coupling molecule, or the stereoisomer, hydrate, deuterium-substituted form, ester, solvate, crystal form, metabolite, pharmaceutically acceptable salt or prodrug thereof may effectively against nontuberculous mycobacteria, and then may be used for treating infection caused by nontuberculous mycobacteria.

Abstract: The present invention discloses a Lithium ion battery and an electrolyte thereof, the electrolyte comprising an organic solvent, a lithium salt and an additive. The additive comprises additive (A) cyclic fluoro carbonate, additive (B) cyclic phosphazene (B), and additive (C) cyclic sulfate. The additive B cyclic phosphazene has the following general structural formula: Compared with the prior art, the electrolyte of the present invention may form a stable CEI and SEI film on the surface of positive and negative electrodes, protect the interface between positive and negative electrodes, improve the acidic atmosphere of Lithium ion battery electrolyte, and reduce the damage effect of HF on the interface between positive and negative electrodes, thereby improving cycle life, high temperature storage performance, and safety performance of lithium-ion battery.

Abstract: The present disclosure provides an electrolyte and an electrochemical energy storage device. The electrolyte comprises an electrolyte salt and an additive. The additive comprises a sulfonic ester cyclic quaternary ammonium salt and a fluorocarbon surfactant. Under the combined effect of the sulfonic ester cyclic quaternary ammonium salt and the fluorocarbon surfactant, a dense, uniform and stable passive film can form on a surface of each of a positive electrode film and a negative electrode film of the electrochemical energy storage device, and infiltration capability of the electrolyte on each of the passive film of the positive electrode film and the negative electrode film can be increased at the same time, so as to decrease electrode polarization inside the electrochemical energy storage device and make the electrochemical energy storage device have excellent rate capability, low temperature discharge performance and high temperature storage performance.

Abstract: The present disclosure provides an electrolyte and an electrochemical energy storage device. The electrolyte comprises an electrolyte salt and an additive. The additive comprises a sulfonic ester cyclic quaternary ammonium salt and a dioxide heterocyclic compound. Under the combined effect of the sulfonic ester cyclic quaternary ammonium salt and the dioxide heterocyclic compound, a dense, uniform and stable passive film on a surface of each of the positive electrode film and the negative electrode film of the electrochemical energy storage device, thereby reducing the contact between the positive, negative electrode active materials and the electrolyte, thus avoiding the occurrence of continuous oxidation and reduction reaction of the electrolyte on the surface of each of the positive electrode film and the negative electrode film, so as to make the electrochemical energy storage device has excellent high temperature storage performance and high temperature cycle performance.

Abstract: A method of inhibiting anaerobic bacteria includes administering to a patient in need thereof a rifamycin-nitroimidazole conjugate molecule shown in formula I. The rifamycin-nitroimidazole conjugate molecule shown in formula I of the present invention has broad-spectrum antibacterial activity against anaerobic bacteria, including activity against most pathogenic bacteria associated with bacterial vaginosis, in vitro antibacterial activity stronger than that of drugs against bacterial vaginosis such as metronidazole and clindamycin, and potential use in prevention and treatment of bacterial vaginosis or other related diseases caused by anaerobic bacteria.

Abstract: A method of inhibiting gastrointestinal ammonia-producing bacteria includes administering to a patient in need thereof a rifamycin-quinolizidone dual-action molecule shown in formula I. The rifamycin-quinolizidone dual-action molecule shown in formula I of present invention has an antibacterial spectrum similar to that of rifaximin, stronger antibacterial activity against the gastrointestinal common ammonia-producing bacteria, low frequency for resistance development, and potential use in prevention and treatment of hepatic encephalopathy and related bacterial infections.